EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 27.21 and traded as low as GBX 24. EKF Diagnostics shares last traded at GBX 24.10, with a volume of 246,568 shares.
EKF Diagnostics Stock Performance
The stock’s 50-day moving average price is GBX 25.39 and its 200-day moving average price is GBX 27.21. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The company has a market capitalization of £108.03 million, a price-to-earnings ratio of 18.44 and a beta of 0.57.
Insider Transactions at EKF Diagnostics
In other news, insider Julian Baines acquired 85,000 shares of EKF Diagnostics stock in a transaction that occurred on Monday, December 15th. The stock was purchased at an average cost of GBX 23 per share, with a total value of £19,550. Corporate insiders own 39.62% of the company’s stock.
About EKF Diagnostics
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- 1 Hour Once A Day
- [No Brainer Gold Play]: “Show me a better investment.”
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
